NCT01696617View on ClinicalTrials.gov

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 10, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2019

Conditions
Major Depressive Disorder
Interventions
DRUG

Aripiprazole 6-week group

DRUG

Aripiprazole 8-week group

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER